Rudolf A. Heijtink

1.0k total citations
23 papers, 743 citations indexed

About

Rudolf A. Heijtink is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rudolf A. Heijtink has authored 23 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Rudolf A. Heijtink's work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (13 papers). Rudolf A. Heijtink is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (13 papers). Rudolf A. Heijtink collaborates with scholars based in Netherlands, Belgium and United Kingdom. Rudolf A. Heijtink's co-authors include Solko W. Schalm, Harry L.A. Janssen, J. Kruining, P.M. Grosheide, René R. P. de Vries, Wim C.J. Hop, Pieter Honkoop, P. Michielsen, Nikolai V. Naoumov and Jan van Hattum and has published in prestigious journals such as Hepatology, PEDIATRICS and FEBS Letters.

In The Last Decade

Rudolf A. Heijtink

23 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rudolf A. Heijtink Netherlands 17 655 568 148 72 39 23 743
Susan Negus United States 17 848 1.3× 793 1.4× 143 1.0× 35 0.5× 76 1.9× 22 970
A. Roumeliotou‐Karayannis Greece 14 573 0.9× 511 0.9× 99 0.7× 28 0.4× 73 1.9× 31 667
WilliamL. Heyward United States 7 328 0.5× 260 0.5× 87 0.6× 25 0.3× 26 0.7× 8 439
Mario Starace Italy 14 417 0.6× 404 0.7× 137 0.9× 66 0.9× 20 0.5× 35 593
Van Thi Thuy Nguyen Vietnam 11 433 0.7× 317 0.6× 154 1.0× 64 0.9× 23 0.6× 29 603
Torkil Moestrup Sweden 14 351 0.5× 349 0.6× 88 0.6× 24 0.3× 23 0.6× 18 513
Hau-Tim Chung Hong Kong 9 431 0.7× 480 0.8× 127 0.9× 22 0.3× 33 0.8× 12 570
Norma de Paula Cavalheiro Brazil 10 389 0.6× 376 0.7× 84 0.6× 10 0.1× 29 0.7× 24 454
L. A. Smallwood United States 9 407 0.6× 375 0.7× 75 0.5× 22 0.3× 38 1.0× 11 479
Phu Dac Tran Vietnam 8 259 0.4× 207 0.4× 102 0.7× 49 0.7× 41 1.1× 13 420

Countries citing papers authored by Rudolf A. Heijtink

Since Specialization
Citations

This map shows the geographic impact of Rudolf A. Heijtink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf A. Heijtink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf A. Heijtink more than expected).

Fields of papers citing papers by Rudolf A. Heijtink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf A. Heijtink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf A. Heijtink. The network helps show where Rudolf A. Heijtink may publish in the future.

Co-authorship network of co-authors of Rudolf A. Heijtink

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf A. Heijtink. A scholar is included among the top collaborators of Rudolf A. Heijtink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf A. Heijtink. Rudolf A. Heijtink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Jinlin, Ralf Schilling, Harry L.A. Janssen, et al.. (2007). Genetic characteristics of hepatitis B virus genotypes as a factor for interferon‐induced HBeAg clearance. Journal of Medical Virology. 79(8). 1055–1063. 28 indexed citations
2.
Janssen, Harry L.A., Guido Gerken, Vicente Carréño, et al.. (1999). Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment. Hepatology. 30(1). 238–243. 115 indexed citations
3.
Brouwer, Johannes T., Frederik Nevens, Bernhard Kleter, et al.. (1998). Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. Journal of Hepatology. 28(6). 951–959. 37 indexed citations
4.
Kleter, Bernhard, Johannes T. Brouwer, Frederik Nevens, et al.. (1998). Hepatitis C virus genotypes: epidemiological and clinical associations. Liver International. 18(1). 32–38. 37 indexed citations
5.
6.
Heijtink, Rudolf A., J. Kruining, Pieter Honkoop, et al.. (1997). Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. Journal of Medical Virology. 53(3). 282–287. 31 indexed citations
7.
Kruining, J., Rudolf A. Heijtink, & Solko W. Schalm. (1995). Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. Journal of Hepatology. 22(3). 263–267. 31 indexed citations
8.
Heijtink, Rudolf A., et al.. (1995). Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an “inhibition in solution” assay. Hepatology. 22(4). 1078–1083. 19 indexed citations
9.
Janssen, Harry L.A., et al.. (1994). Measurement of HBsAg to monitor hepatitis B viral replication in patients on α-interferon therapy. Antiviral Research. 23(3-4). 251–257. 45 indexed citations
10.
Grosheide, P.M., et al.. (1994). Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. Journal of Hepatology. 20(4). 483–486. 91 indexed citations
11.
Janssen, Harry L.A., et al.. (1993). Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays. Journal of Medical Virology. 40(4). 307–312. 16 indexed citations
12.
Janssen, Harry L.A., et al.. (1993). Repeated courses of α-interferon for treatment of chronic hepatitis type B. Journal of Hepatology. 17. S47–S51. 27 indexed citations
13.
Kate, Fiebo J.W. ten, et al.. (1992). Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. Journal of Hepatology. 14(2-3). 168–175. 11 indexed citations
14.
Schalm, Solko W., et al.. (1992). Zidovudine inhibits hepatitis B virus replication. Antiviral Research. 19(2). 111–118. 12 indexed citations
15.
Grosheide, P.M., et al.. (1991). Immunoprophylaxis to limit a hepatitis B epidemic among women undergoing in vitro fertilization. Vaccine. 9(9). 682–687. 6 indexed citations
16.
Drogendijk, A. C., et al.. (1991). The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. American Journal of Obstetrics and Gynecology. 165(1). 152–159. 25 indexed citations
17.
Quint, Wim, et al.. (1990). HBV-DNA detection by gene amplification in acute hepatitis B. Hepatology. 12(4). 653–656. 21 indexed citations
18.
Heijtink, Rudolf A., et al.. (1989). Long‐term immune reactivity to pre‐S(2)‐antigen after acute hepatitis B infection. Journal of Medical Virology. 27(2). 95–99. 8 indexed citations
19.
Heijtink, Rudolf A., Pieter de Jong, Solko W. Schalm, & N. Masurel. (1984). Hepatitis B Vaccination in Down’s Syndrome and Other Mentally Retarded Patients. Hepatology. 4(4). 611–614. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Negus Breakdown of academic impact, for papers by A. Roumeliotou‐Karayannis Breakdown of academic impact, for papers by WilliamL. Heyward Breakdown of academic impact, for papers by Mario Starace Breakdown of academic impact, for papers by Van Thi Thuy Nguyen Breakdown of academic impact, for papers by Torkil Moestrup Breakdown of academic impact, for papers by Hau-Tim Chung Breakdown of academic impact, for papers by Norma de Paula Cavalheiro Breakdown of academic impact, for papers by L. A. Smallwood Breakdown of academic impact, for papers by Phu Dac Tran
Rankless by CCL
2026